Cargando…

Static and treatment-responsive brain biomarkers of depression relapse vulnerability following prophylactic psychotherapy: Evidence from a randomized control trial

BACKGROUND: Neural reactivity to dysphoric mood induction indexes the tendency for distress to promote cognitive reactivity and sensory avoidance. Linking these responses to illness prognosis following recovery from Major Depressive Disorder informs our understanding of depression vulnerability and...

Descripción completa

Detalles Bibliográficos
Autores principales: Farb, Norman A.S., Desormeau, Philip, Anderson, Adam K., Segal, Zindel V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978278/
https://www.ncbi.nlm.nih.gov/pubmed/35367955
http://dx.doi.org/10.1016/j.nicl.2022.102969
_version_ 1784680935916044288
author Farb, Norman A.S.
Desormeau, Philip
Anderson, Adam K.
Segal, Zindel V.
author_facet Farb, Norman A.S.
Desormeau, Philip
Anderson, Adam K.
Segal, Zindel V.
author_sort Farb, Norman A.S.
collection PubMed
description BACKGROUND: Neural reactivity to dysphoric mood induction indexes the tendency for distress to promote cognitive reactivity and sensory avoidance. Linking these responses to illness prognosis following recovery from Major Depressive Disorder informs our understanding of depression vulnerability and provides engagement targets for prophylactic interventions. METHODS: A prospective fMRI neuroimaging design investigated the relationship between dysphoric reactivity and relapse following prophylactic intervention. Remitted depressed outpatients (N = 85) were randomized to 8 weeks of Cognitive Therapy with a Well-Being focus or Mindfulness Based Cognitive Therapy. Participants were assessed before and after therapy and followed for 2 years to assess relapse status. Neural reactivity common to both assessment points identified static biomarkers of relapse, whereas reactivity change identified dynamic biomarkers. RESULTS: Dysphoric mood induction evoked prefrontal activation and sensory deactivation. Controlling for past episodes, concurrent symptoms and medication status, somatosensory deactivation was associated with depression recurrence in a static pattern that was unaffected by prophylactic treatment, HR 0.04, 95% CI [0.01, 0.14], p < .001. Treatment-related prophylaxis was linked to reduced activation of the left lateral prefrontal cortex (LPFC), HR 3.73, 95% CI [1.33, 10.46], p = .013. Contralaterally, the right LPFC showed dysphoria-evoked inhibitory connectivity with the right somatosensory biomarker CONCLUSIONS: These findings support a two-factor model of depression relapse vulnerability, in which: enduring patterns of dysphoria-evoked sensory deactivation contribute to episode return, but vulnerability may be mitigated by targeting prefrontal regions responsive to clinical intervention. Emotion regulation during illness remission may be enhanced by reducing prefrontal cognitive processes in favor of sensory representation and integration.
format Online
Article
Text
id pubmed-8978278
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-89782782022-04-05 Static and treatment-responsive brain biomarkers of depression relapse vulnerability following prophylactic psychotherapy: Evidence from a randomized control trial Farb, Norman A.S. Desormeau, Philip Anderson, Adam K. Segal, Zindel V. Neuroimage Clin Regular Article BACKGROUND: Neural reactivity to dysphoric mood induction indexes the tendency for distress to promote cognitive reactivity and sensory avoidance. Linking these responses to illness prognosis following recovery from Major Depressive Disorder informs our understanding of depression vulnerability and provides engagement targets for prophylactic interventions. METHODS: A prospective fMRI neuroimaging design investigated the relationship between dysphoric reactivity and relapse following prophylactic intervention. Remitted depressed outpatients (N = 85) were randomized to 8 weeks of Cognitive Therapy with a Well-Being focus or Mindfulness Based Cognitive Therapy. Participants were assessed before and after therapy and followed for 2 years to assess relapse status. Neural reactivity common to both assessment points identified static biomarkers of relapse, whereas reactivity change identified dynamic biomarkers. RESULTS: Dysphoric mood induction evoked prefrontal activation and sensory deactivation. Controlling for past episodes, concurrent symptoms and medication status, somatosensory deactivation was associated with depression recurrence in a static pattern that was unaffected by prophylactic treatment, HR 0.04, 95% CI [0.01, 0.14], p < .001. Treatment-related prophylaxis was linked to reduced activation of the left lateral prefrontal cortex (LPFC), HR 3.73, 95% CI [1.33, 10.46], p = .013. Contralaterally, the right LPFC showed dysphoria-evoked inhibitory connectivity with the right somatosensory biomarker CONCLUSIONS: These findings support a two-factor model of depression relapse vulnerability, in which: enduring patterns of dysphoria-evoked sensory deactivation contribute to episode return, but vulnerability may be mitigated by targeting prefrontal regions responsive to clinical intervention. Emotion regulation during illness remission may be enhanced by reducing prefrontal cognitive processes in favor of sensory representation and integration. Elsevier 2022-02-19 /pmc/articles/PMC8978278/ /pubmed/35367955 http://dx.doi.org/10.1016/j.nicl.2022.102969 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
Farb, Norman A.S.
Desormeau, Philip
Anderson, Adam K.
Segal, Zindel V.
Static and treatment-responsive brain biomarkers of depression relapse vulnerability following prophylactic psychotherapy: Evidence from a randomized control trial
title Static and treatment-responsive brain biomarkers of depression relapse vulnerability following prophylactic psychotherapy: Evidence from a randomized control trial
title_full Static and treatment-responsive brain biomarkers of depression relapse vulnerability following prophylactic psychotherapy: Evidence from a randomized control trial
title_fullStr Static and treatment-responsive brain biomarkers of depression relapse vulnerability following prophylactic psychotherapy: Evidence from a randomized control trial
title_full_unstemmed Static and treatment-responsive brain biomarkers of depression relapse vulnerability following prophylactic psychotherapy: Evidence from a randomized control trial
title_short Static and treatment-responsive brain biomarkers of depression relapse vulnerability following prophylactic psychotherapy: Evidence from a randomized control trial
title_sort static and treatment-responsive brain biomarkers of depression relapse vulnerability following prophylactic psychotherapy: evidence from a randomized control trial
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978278/
https://www.ncbi.nlm.nih.gov/pubmed/35367955
http://dx.doi.org/10.1016/j.nicl.2022.102969
work_keys_str_mv AT farbnormanas staticandtreatmentresponsivebrainbiomarkersofdepressionrelapsevulnerabilityfollowingprophylacticpsychotherapyevidencefromarandomizedcontroltrial
AT desormeauphilip staticandtreatmentresponsivebrainbiomarkersofdepressionrelapsevulnerabilityfollowingprophylacticpsychotherapyevidencefromarandomizedcontroltrial
AT andersonadamk staticandtreatmentresponsivebrainbiomarkersofdepressionrelapsevulnerabilityfollowingprophylacticpsychotherapyevidencefromarandomizedcontroltrial
AT segalzindelv staticandtreatmentresponsivebrainbiomarkersofdepressionrelapsevulnerabilityfollowingprophylacticpsychotherapyevidencefromarandomizedcontroltrial